Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

被引:346
作者
Milich, D
Liang, TJ
机构
[1] Vaccine Res Inst San Diego, San Diego, CA 92109 USA
[2] NIDDK, Liver Dis Sect, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/jhep.2003.50453
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The function of the hepatitis B e antigen (HBeAg) is largely unknown because it is not required for viral assembly, replication, or infection. In this report we chronicle clinical and experimental studies in an attempt to understand the role of HBeAg in natural infection. These studies largely have focused on clinical-pathologic features of HBeAg-negative variants in acute and chronic HBV infection, mutational analysis in animal models of hepadnavirus infection, and the use of transgenic murine models. The clinical and experimental data suggest that serum HBeAg may serve an immunoregulatory role in natural infection. To the contrary, cytosolic HBeAg serves as a target for the inflammatory immune response. These dual roles of the HBeAg and its ability to activate or tolerize T cells show the complexity of the interactions between the HBeAg and the host during HBV infection.
引用
收藏
页码:1075 / 1086
页数:12
相关论文
共 105 条
  • [41] CHANGES IN THE PREVALENCE OF HBEAG-NEGATIVE MUTANT HEPATITIS-B VIRUS DURING THE COURSE OF CHRONIC HEPATITIS-B
    HAMASAKI, K
    NAKATA, K
    NAGAYAMA, Y
    OHTSURU, A
    DAIKOKU, M
    TANIGUCHI, K
    TSUTSUMI, T
    SATO, Y
    KATO, Y
    NAGATAKI, S
    [J]. HEPATOLOGY, 1994, 20 (01) : 8 - 14
  • [42] CELLULAR IMMUNE-RESPONSE TO HBCAG IN MOTHER-TO-INFANT TRANSMISSION OF HEPATITIS-B VIRUS
    HSU, HY
    CHANG, MH
    HSIEH, KH
    LEE, CY
    LIN, HH
    HWANG, LH
    CHEN, PJ
    CHEN, DS
    [J]. HEPATOLOGY, 1992, 15 (05) : 770 - 776
  • [43] ISHIKAWA T, 1993, IMMUNOLOGY, V80, P313
  • [44] ACTIVATION OF A HETEROGENEOUS HEPATITIS-B (HB) CORE AND E-ANTIGEN-SPECIFIC CD4(+) T-CELL POPULATION DURING SEROCONVERSION TO ANTI-HBE AND ANTI-HBS IN HEPATITIS-B VIRUS-INFECTION
    JUNG, MC
    DIEPOLDER, HM
    SPENGLER, U
    WIERENGA, EA
    ZACHOVAL, R
    HOFFMANN, RM
    EICHENLAUB, D
    FROSNER, G
    WILL, H
    PAPE, GR
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3358 - 3368
  • [45] Response to interferon-alpha 2a in patients with e antigen-negative chronic hepatitis B
    Kako, M
    Kanai, K
    Aikawa, T
    Iwabuchi, S
    Takehira, Y
    Kawasaki, T
    Tsubouchi, H
    Hino, K
    Tsuda, F
    Okamoto, H
    Miyakawa, Y
    Mayumi, M
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1997, 25 (02) : 440 - 445
  • [46] A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis
    Kalinina, T
    Riu, A
    Fischer, L
    Will, H
    Sterneck, M
    [J]. HEPATOLOGY, 2001, 34 (02) : 385 - 394
  • [47] Kuhober A, 1996, J IMMUNOL, V156, P3687
  • [48] PRECORE-MEDIATED INHIBITION OF HEPATITIS-B VIRUS PROGENY DNA-SYNTHESIS
    LAMBERTS, C
    NASSAL, M
    VELHAGEN, I
    ZENTGRAF, H
    SCHRODER, CH
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (07) : 3756 - 3762
  • [49] Lampertico P, 1997, HEPATOLOGY, V26, P1621, DOI 10.1002/hep.510260634
  • [50] NUCLEOTIDE-SEQUENCE ANALYSIS OF THE PRECORE REGION IN PATIENTS WITH FULMINANT HEPATITIS-B IN THE UNITED-STATES
    LASKUS, T
    PERSING, DH
    NOWICKI, MJ
    MOSLEY, JW
    RAKELA, J
    [J]. GASTROENTEROLOGY, 1993, 105 (04) : 1173 - 1178